인쇄하기
취소
|
Medicines which were successively ran out of stock, such as Xarelto and Atozet, have alerted pharmacies and pharmaceutical distribution companies on product supply.
The Bayer Korea’s Xarelto supply is expected to be temporarily suspended from the 23rd of October as the company need to re-package the products to follow changes in its product approval. The products which will be repackaged are X...